Profile data is unavailable for this security.
About the company
LivaNova PLC is a medical device company focused on the development and delivery of important products and therapies for the benefit of patients, healthcare professionals and healthcare systems throughout the world. The Company designs, develops, manufactures and sells products and therapies to provide improvements for both the head and heart. The Company operates in three reportable segments: Cardiopulmonary, Neuromodulation and Advanced Circulatory Support. Its Cardiac Surgery Business Franchise (CS) is engaged in the development, production and sale of cardiac surgery products, including oxygenators, heart-lung machines, perfusion tubing systems, cannulae and other accessories used for extracorporeal circulation, systems for autologous blood transfusion and blood washing. Its Neuromodulation Business Franchise designs develops and markets neuromodulation-based medical devices for the treatment of epilepsy and difficult-to-treat depression (DTD) and obstructive sleep apnea.
- Revenue in USD (TTM)1.02bn
- Net income in USD-96.47m
- Incorporated2015
- Employees3.00k
- LocationLivaNova PLC20 Eastbourne TerraceLONDON W2 6LGUnited KingdomGBR
- Phone+44 203 325 0662
- Websitehttp://www.livanova.com/home.action
More ▼
Mergers & acquisitions
| Acquired company | LIVN:NSQ since announced | Transaction value |
|---|---|---|
| ALung Technologies Inc | -27.35% | 110.00m |
Data delayed at least 15 minutes, as of Dec 02 2022 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procept Biorobotics Corp | 49.69m | -68.82m | 2.05bn | 234.00 | -- | 8.55 | -- | 41.31 | -1.56 | -1.56 | 1.13 | 5.37 | 0.1982 | 2.02 | 6.20 | 212,367.50 | -27.45 | -- | -29.34 | -- | 50.18 | -- | -138.49 | -- | 15.27 | -11.26 | 0.1744 | -- | 346.72 | -- | -12.89 | -- | -- | -- |
| NuVasive, Inc. | 1.20bn | -20.41m | 2.09bn | 2.90k | -- | 2.50 | 16.36 | 1.74 | -0.4583 | -0.4583 | 21.95 | 15.98 | 0.5563 | 1.01 | 5.51 | 413,299.30 | -0.9471 | 0.3758 | -1.19 | 0.4499 | 72.53 | 72.00 | -1.70 | 0.6706 | 0.7202 | 1.64 | 0.5172 | 0.00 | 8.41 | 3.43 | -72.49 | -- | 3.59 | -- |
| AtriCure Inc. | 315.57m | -56.04m | 2.14bn | 875.00 | -- | 4.74 | -- | 6.77 | -1.23 | -1.23 | 6.92 | 9.70 | 0.5282 | 1.93 | 8.42 | 360,650.30 | -9.38 | -3.47 | -10.35 | -3.81 | 74.74 | 73.42 | -17.76 | -7.46 | 2.92 | -13.31 | 0.1353 | -- | 32.83 | 12.08 | 204.24 | -- | 4.86 | -- |
| Glaukos Corp | 284.88m | -89.61m | 2.32bn | 727.00 | -- | 4.23 | -- | 8.15 | -1.90 | -1.90 | 5.95 | 11.51 | 0.2749 | 2.55 | 8.14 | 391,850.10 | -8.65 | -6.01 | -9.20 | -6.48 | 75.91 | 77.83 | -31.45 | -15.28 | 6.84 | -8.01 | 0.3918 | -- | 30.70 | 20.78 | 58.79 | -- | 50.07 | -- |
| Helen of Troy Limited | 2.24bn | 170.74m | 2.43bn | 2.15k | 14.39 | 1.74 | 11.53 | 1.09 | 7.04 | 7.04 | 92.38 | 58.34 | 0.7951 | 2.02 | 4.78 | 1,042,117.00 | 6.07 | 9.67 | 7.69 | 12.18 | 43.42 | 42.63 | 7.63 | 10.40 | 1.02 | 13.14 | 0.4555 | -- | 5.93 | 9.73 | -8.51 | 9.17 | 38.15 | -- |
| Integer Holdings Corp | 1.32bn | 68.26m | 2.45bn | 9.00k | 36.16 | 1.81 | 15.56 | 1.86 | 2.05 | 2.16 | 39.52 | 40.90 | 0.5177 | 5.41 | 5.02 | 146,298.70 | 2.68 | 2.91 | 2.89 | 3.13 | 26.11 | 28.70 | 5.18 | 6.22 | 1.74 | 2.83 | 0.4092 | 0.00 | 13.75 | 2.57 | 20.40 | 30.18 | -1.83 | -- |
| Pacific Biosciences of California Inc | 136.97m | -299.19m | 2.51bn | 728.00 | -- | 3.99 | -- | 18.29 | -1.34 | -1.34 | 0.6137 | 2.77 | 0.0711 | 2.47 | 5.87 | 188,145.60 | -15.53 | -22.10 | -16.10 | -24.57 | 44.29 | 39.32 | -218.44 | -91.18 | 10.66 | -19.58 | 0.5886 | -- | 65.43 | 7.55 | -716.34 | -- | -6.29 | -- |
| Conmed Corp | 1.07bn | -82.72m | 2.67bn | 3.80k | -- | 3.72 | -- | 2.49 | -2.91 | -2.91 | 34.72 | 23.50 | 0.5282 | 1.77 | 5.89 | 281,203.90 | -4.09 | 2.11 | -4.53 | 2.36 | 55.93 | 55.04 | -7.74 | 3.66 | 1.29 | 3.63 | 0.5914 | 69.26 | 17.18 | 5.77 | 557.16 | 33.65 | 0.1527 | 0.00 |
| Tandem Diabetes Care Inc | 790.71m | -67.93m | 2.74bn | 2.00k | -- | 6.49 | -- | 3.47 | -1.06 | -1.06 | 12.31 | 6.56 | 0.8333 | 4.45 | 7.90 | 395,356.00 | -7.16 | -15.69 | -8.47 | -19.84 | 52.00 | 52.00 | -8.59 | -15.67 | 4.20 | -19.11 | 0.4013 | -- | 40.89 | 52.85 | 145.27 | -- | 21.36 | -- |
| Patterson Companies, Inc. | 6.41bn | 193.80m | 2.80bn | 7.70k | 14.60 | 2.71 | 10.21 | 0.4364 | 1.97 | 1.97 | 65.15 | 10.59 | 2.33 | 6.18 | 17.23 | 832,181.10 | 6.98 | -0.1828 | 11.32 | -0.2691 | 20.65 | 21.18 | 3.00 | -0.0968 | 0.7965 | -- | 0.3816 | -- | 9.93 | 3.05 | 30.28 | 3.18 | -4.02 | 1.20 |
| STAAR Surgical Company | 279.35m | 37.82m | 2.85bn | 692.00 | 77.17 | 8.90 | 68.04 | 10.20 | 0.7663 | 0.7663 | 5.66 | 6.64 | 0.7767 | 3.33 | 5.74 | 403,682.10 | 10.52 | 5.83 | 12.06 | 7.08 | 78.25 | 74.44 | 13.54 | 6.98 | 6.11 | 10.26 | 0.0013 | 0.00 | 41.00 | 22.83 | 314.36 | -- | 33.61 | -- |
| LivaNova PLC | 1.02bn | -96.47m | 3.01bn | 3.00k | -- | 2.62 | -- | 2.96 | -1.81 | -1.81 | 18.91 | 21.43 | 0.4606 | 2.41 | 5.74 | 338,998.30 | -4.37 | -5.98 | -5.56 | -7.34 | 70.92 | 65.94 | -9.48 | -14.04 | 2.53 | 0.8195 | 0.3201 | -- | 10.82 | 1.42 | 60.90 | -- | -7.86 | -- |
| Adapthealth Corp | 2.89bn | 86.96m | 3.05bn | 10.70k | 35.52 | 1.41 | 7.18 | 1.05 | 0.6365 | 0.6365 | 15.52 | 16.08 | 0.5547 | 21.18 | 8.20 | 270,319.40 | 1.88 | -- | 2.08 | -- | 17.53 | -- | 3.39 | -- | 1.08 | 2.75 | 0.504 | -- | 132.35 | -- | 187.73 | -- | -- | -- |
| Inmode Ltd | 431.24m | 176.50m | 3.17bn | 362.00 | 18.49 | 6.24 | 17.91 | 7.36 | 2.06 | 2.06 | 5.05 | 6.12 | 0.8401 | 2.52 | 17.02 | 1,191,271.00 | 34.38 | 37.64 | 38.59 | 45.48 | 83.92 | 85.26 | 40.93 | 38.01 | 9.12 | 828.05 | 0.00 | 0.00 | 73.49 | 72.99 | 119.87 | 245.31 | 37.94 | -- |
| Axonics Inc | 240.92m | -75.53m | 3.51bn | 517.00 | -- | 6.38 | -- | 14.57 | -1.66 | -1.66 | 5.28 | 11.11 | 0.4037 | 1.11 | 7.58 | 465,994.20 | -12.66 | -25.46 | -13.67 | -28.70 | 70.60 | 62.16 | -31.35 | -86.62 | 6.44 | -52.96 | 0.00 | -- | 61.64 | -- | -45.80 | -- | 50.57 | -- |
| ICU Medical Inc | 2.04bn | -38.83m | 3.90bn | 8.50k | -- | 1.94 | 23.90 | 1.91 | -1.57 | -1.57 | 87.50 | 83.94 | 0.6495 | 3.04 | 12.42 | 240,295.10 | -1.23 | 5.01 | -1.38 | 5.76 | 31.84 | 36.98 | -1.90 | 5.99 | 1.17 | 1.02 | 0.4515 | 0.00 | 3.56 | 28.25 | 18.72 | 10.33 | 27.02 | -- |
Data as of Dec 02 2022. Currency figures normalised to LivaNova PLC's reporting currency: US Dollar USD
49.50%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2022 | 5.67m | 10.58% |
| PRIMECAP Management Co.as of 30 Sep 2022 | 4.58m | 8.55% |
| Harris Associates LPas of 30 Sep 2022 | 3.59m | 6.71% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 2.56m | 4.78% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 30 Sep 2022 | 2.44m | 4.55% |
| Eminence Capital LPas of 30 Sep 2022 | 2.09m | 3.90% |
| Redmile Group LLCas of 30 Sep 2022 | 1.54m | 2.87% |
| Sachem Head Capital Management LPas of 30 Sep 2022 | 1.54m | 2.87% |
| Hawk Ridge Capital Management LPas of 30 Sep 2022 | 1.28m | 2.39% |
| The Vanguard Group, Inc.as of 30 Sep 2022 | 1.24m | 2.32% |
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
